Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Annesley Jr WH . Peripheral exudative hemorrhagic chorioretinopathy. Trans Am Opthalmol Soc 1980; 78: 321–364.
Alforja MS, Sabater N, Giralt J, Adán A, PelegrÃn L, Casaroli-Marano R . Intravitreal bevacizumab injection for peripheral exudative hemorrhagic chorioretinopathy. Jpn J Ophthalmol 2011; 55 (4): 425–427.
Kim YT, Kang SW, Lee JH, Chiung SE . Peripheral exudative hemorrhagic chorioretinopathy in Korean patients. Jpn J Ophthalmol 2010; 54 (3): 227–231.
Barkmeier AJ, Kadikoy H, Holz ER, Carvounis PE . Regression of serous macular detachment due to peripheral exudativehemorrhagic chorioretinopathy following intravitreal bevacizumab. Eur J Ophthalmol 2011; 21 (4): 506–508.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
This report was presented at the 12th EURETINA Congress and the XXIX Congress of the ESCRS meeting, Milan, Italy, September 2012.
Rights and permissions
About this article
Cite this article
Pinarci, E., Kilic, I., Bayar, S. et al. Clinical characteristics of peripheral exudative hemorrhagic chorioretinopathy and its response to bevacizumab therapy. Eye 27, 111–112 (2013). https://doi.org/10.1038/eye.2012.239
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2012.239
This article is cited by
-
Unklarer Aderhauttumor mit Blutungen
Der Ophthalmologe (2018)
-
Anti-VEGF therapy in symptomatic peripheral exudative hemorrhagic chorioretinopathy (PEHCR) involving the macula
Graefe's Archive for Clinical and Experimental Ophthalmology (2016)
